FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!
FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome.
(Editors note: a...
Dalrada (DFCO) Records First Sales of LikidoVOLT® Independent Power Generators With Hidden Villa Ranch
One of the nation’s largest global egg and dairy distributors, Hidden Villa Ranch, adds LikidoVOLT ® to its sustainability initiatives for clean power generation resulting in...
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
We're up 370% since adding it to the Biotech Stock Review Watch List...
Athersys (ATHX) Overview and Due Diligence links (Reddit)
I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are a newcomer...
Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021 @$1.80Cash has Risen From $3.3 Million...
Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).
Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR)
Summary
IDMC meets on June 29 for Superiority review.Mino-Lok has no competition.Price target increased to...
Video: Mel Gibson Stem Cell Testimonial.
Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert.
Joe Rogan interviews Stem Cell Institute founder Neil...
Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.
The 2021 Biotech Six Pack, Six Stocks We Expect to Double.
We're still putting the 2021 list together now, but rather than waiting to announce...
Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.
Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what HOOT-N-HOLLER.
LIVE CHART
RELATED:...
Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
https://youtu.be/vMIy8xWLOKI?t=3699
INSIDER HOLDINGS
POWERPOINT
LIVE CHART
Adding Citius (CTXR) $0.55 to Watch List.
Citius News Archive
MARKET BEAT
TIP RANKS
Disclaimer. Citius Pharma is a client, please see reports for disclosure and...
Latest article
Fairchild Gold Corp., Presenting at Palm Beach Investor Roadshow.
Vancouver, British Columbia and Las Vegas, Nevada--(Institutional Analyst - April 8th, 2026) - Fairchild Gold Corp. (TSXV: FAIR) (FSE: Y4Y) (OTCQB: FCHDF) ("Fairchild" or the "Company"),...
Precious Metals Analyst | Mark Reichman | Noble Capital
Mark Reichman
Senior Research Analyst, Industrials and Basic Industries
BIO
Mark joined Noble as a senior research analyst with coverage responsibility in the Industrials and Basic Industries...
